<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700945</url>
  </required_header>
  <id_info>
    <org_study_id>Stroke AF</org_study_id>
    <nct_id>NCT02700945</nct_id>
  </id_info>
  <brief_title>Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin</brief_title>
  <official_title>Stroke AF - Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the Stroke AF study is to compare the incidence of atrial fibrillation (AF)
      through 12 months between continuous cardiac rhythm monitoring with the Reveal LINQ™
      Insertable Cardiac Monitor (ICM) (continuous monitoring arm) and standard of care (SoC)
      medical treatment (control arm) in subjects with a recent ischemic stroke of presumed known
      origin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke AF is a prospective, multi-site, randomized, controlled, non-blinded, post-market
      study. The Stroke AF study will compare the incidence rate of atrial fibrillation through 12
      months between the continuous monitoring arm and the control arm in subjects with a recent
      ischemic stroke of presumed known origin. Subjects randomized to the continuous monitoring
      arm will have a Reveal LINQ Insertable Cardiac Monitor inserted within 10 days of the
      qualifying stroke and undergo continuous remote monitoring. Subjects randomized to the
      control arm will be followed per site specific standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects will be randomized 1:1 to the continuous monitoring arm or the control arm. Subjects randomized to the continuous monitoring arm will have a Reveal LINQ ICM inserted within 10 days of the qualifying stroke and undergo continuous remote monitoring. Subjects randomized to the control arm will be followed per site specific standard of care.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective is to compare the incidence rate of AF through 12 months between the continuous monitoring arm vs control arm in subjects with a recent ischemic stroke of presumed known origin.</measure>
    <time_frame>12 months</time_frame>
    <description>AF will be defined as an AF event lasting more than 30 seconds. The first AF episode detected and adjudicated by the endpoint adjudication committee will be used for this analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the incidence rates of AF through the duration of study follow-up between study arms.</measure>
    <time_frame>3 years</time_frame>
    <description>AF will be defined as an AF event lasting more than 30 seconds. The first AF episode detected and adjudicated by the endpoint adjudication committee will be used for this analysis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">496</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Reveal LINQ™ Insertable Cardiac Monitor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to the Reveal LINQ™ Insertable Cardiac Monitor arm will be continuously monitored via the inserted Reveal LINQ™ device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects randomized to the control arm will be followed per site specific standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reveal LINQ™ Insertable Cardiac Monitor</intervention_name>
    <description>The Medtronic Reveal LINQ™ ICM is a programmable device that continuously monitors a patient's ECG (electrocardiogram) and other physiological parameters. The device records cardiac information in response to automatically detected arrhythmias and patient activation.</description>
    <arm_group_label>Reveal LINQ™ Insertable Cardiac Monitor</arm_group_label>
    <other_name>LINQ</other_name>
    <other_name>LINQ™</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has had an ischemic stroke believed to be due to small vessel disease, large
             vessel cervical or intracranial atherosclerosis within the past 10 days

          -  Subject is willing and able to undergo study requirements and expected to be
             geographically stable during study follow-up

          -  Subject is 60 years of age or older, or age 50 to 59 years plus a documented medical
             history of at least one of the following additional risk factors for stroke:

               -  Congestive heart failure

               -  Hypertension (Systolic Blood Pressure &gt; 140)

               -  Diabetes Mellitus

               -  Prior Stroke (&gt;90 days ago, other than study qualifying index event)

               -  Vascular disease (e.g. coronary artery disease, heart attack, peripheral artery
                  disease and complex aortic plaque)

        Exclusion Criteria:

          -  Subject has had a cryptogenic stroke

          -  Subject has had a cardioembolic stroke

          -  Subject has untreated hyperthyroidism

          -  Subject has had a recent myocardial infarction &lt;1 month of stroke

          -  Subject has had a recent cardiac surgery (e.g. coronary artery bypass surgery (CABG))
             &lt;1 month of stroke

          -  Subject has a mechanical heart valve

          -  Subject has valvular disease requiring immediate surgical intervention

          -  Subject has documented prior history of atrial fibrillation or atrial flutter

          -  Subject has permanent indication for oral anticoagulation

          -  Subject has permanent contraindication to oral anticoagulation such that detection of
             AF would not change medical management, based on enrolling investigators judgment

          -  Subject is enrolled in a concurrent study that may confound the results of this study.
             Co-enrollment in any concurrent clinical study (including registries) requires
             approval of the study manager or designee.

          -  Subject's life expectancy is less than 1 year

          -  Subject is pregnant

          -  Subject has or is indicated for implant with a pacemaker, Implantable Cardioverter
             Defibrillator (ICD), Cardiac ResynchronizationTherapy (CRT), or an implantable
             hemodynamic monitor

          -  Subject with a medical condition that precludes the patient from participation in the
             opinion of the investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Bernstein, PhD/MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lee Schwamm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mass General</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Megan Mueller, BSN</last_name>
    <phone>800-633-8766</phone>
    <email>megan.d.mueller@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cardiovascular Associates PC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Frew, Study Coordinator</last_name>
      <phone>205-599-6386</phone>
      <email>sfrew@cvapc.com</email>
    </contact>
    <investigator>
      <last_name>Chris Rowley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scripps Green Hospital</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Couts, Study Coordinator</last_name>
      <phone>(858) 824-8463</phone>
      <email>couts.linda@scrippshealth.org</email>
    </contact>
    <investigator>
      <last_name>Mary Kalafut, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Meisel, MD</last_name>
      <email>Karl.Meisel@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Karl Meisel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Innovative Medical Research</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angel Hernandez, Study Coodinator</last_name>
      <phone>305-759-1881</phone>
      <email>innmed2@aol.com</email>
    </contact>
    <investigator>
      <last_name>Howard Kreger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iszet Campo-Bustillo, Study Coordinator</last_name>
      <phone>(305) 243-8018</phone>
      <email>icampo@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Sebastitan Koch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital Neuroscience Institute</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Aly, Study Coordinator</last_name>
      <phone>(407) 303-3243</phone>
      <email>jane.aly@flhosp.org</email>
    </contact>
    <investigator>
      <last_name>Indrani Acosta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Queens Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malia Young, Study Coordinator</last_name>
      <phone>(808) 691-8768</phone>
      <email>mayoung@queens.org</email>
    </contact>
    <investigator>
      <last_name>David Singh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611-5928</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Zavala, Study Coordinator</last_name>
      <phone>312-503-6212</phone>
      <email>Jose.zavala@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Bernstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norton Neuroscience Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Ritchey, Study Coordinator</last_name>
      <phone>(502) 446-8544</phone>
      <email>debbie.ritchey@nortonhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Nadeem Talpur, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Tirrell, Study Coordinator</last_name>
      <phone>(617) 726-9163</phone>
      <email>Gregory.Tirrell@MGH.HARVARD.EDU</email>
    </contact>
    <investigator>
      <last_name>Scott Silverman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Partners Institute</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Daly, Study Coordinator</last_name>
      <phone>651-495-6368</phone>
      <email>Jennifer.J.Daly@HealthPartners.com</email>
    </contact>
    <investigator>
      <last_name>Haitham Hussein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HealthPartners Institute</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55426</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chistina Podias, Study Coordinator</last_name>
      <phone>(214) 818-9688</phone>
      <email>christina.podias1@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Ostrander, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Clinic Cardiology</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Wilcox, Study Coordinator</last_name>
      <phone>(314) 251-7899</phone>
      <email>mary.wilcox@mercy.net</email>
    </contact>
    <investigator>
      <last_name>David Rempe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cox Medical Center South</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Spencer Pittman, Study Coordinator</last_name>
      <phone>(417) 269-7114</phone>
      <email>Spencer.Pittman@coxhealth.com</email>
    </contact>
    <investigator>
      <last_name>Richard Jung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia Arakelian, Study Coordinator</last_name>
      <phone>(551) 996-5722</phone>
      <email>patricia.arakelian@hackensackmeridian.org</email>
    </contact>
    <investigator>
      <last_name>Subasini Dash, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Orvis, Study Coordinator</last_name>
      <phone>(518) 292-6053</phone>
      <email>eorvis@capitalcardiology.com</email>
    </contact>
    <investigator>
      <last_name>Rizwan Alimohammad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University at Buffalo, The State University of New York</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annemarie Crumlish, Study Coordinator</last_name>
      <phone>(716) 887-5200</phone>
      <email>Ac35@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Marilou Ching, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Eng, Study Coordinator</last_name>
      <phone>(516) 881-7046</phone>
      <email>meng2@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Wright, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016-6402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oksana Tatarina, Study Coordinaotr</last_name>
      <phone>(212) 263-7704</phone>
      <email>oksana.tatarina@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Koto Ishida, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Renvill, Study Coordinator</last_name>
      <phone>(212) 241-2220</phone>
      <email>ricardo.renvill@mssm.edu</email>
    </contact>
    <investigator>
      <last_name>Mandip Dhamoon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Overlook Medical Center</name>
      <address>
        <city>Summit</city>
        <state>New York</state>
        <zip>07901-3533</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrice Light, Study Coordinator</last_name>
      <phone>(908) 522-5768</phone>
      <email>Patrice.Light@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Robert Felberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cone Health</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tammy Hedrick, Study Coordinator</last_name>
      <phone>(336) 273-2511</phone>
      <email>tammy.hedrick@conehealth.com</email>
    </contact>
    <investigator>
      <last_name>Pramod Sethi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blair Apple, Study Coordinator</last_name>
      <phone>(405) 271-4658</phone>
      <email>Blair-Apple@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Evgeny Sidorov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sacred Heart</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477-8800</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny OLeary, Study Coodinator</last_name>
      <phone>(541) 912-6653</phone>
      <email>POleary@peacehealth.org</email>
    </contact>
    <investigator>
      <last_name>Elaine Skalabrin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lancaster General Hospital</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Ramsey, Study Coordinator</last_name>
      <phone>(717) 544-1777</phone>
      <email>dramsey2@lghealth.org</email>
    </contact>
    <investigator>
      <last_name>Murray Flaster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Liz DeSanto, Study Coordinator</last_name>
      <phone>(215) 661-4904</phone>
      <email>maryliz.desanto@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Kasner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Research Institute</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hollie Horton, Study Coordinator</last_name>
      <phone>615-222-3865</phone>
      <email>Hollie.Horton@Ascension.org</email>
    </contact>
    <investigator>
      <last_name>Franke LaFranchise, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nazia Iram, Study Coordinator</last_name>
      <phone>(214) 820-9907</phone>
      <email>Nazia.Iram@BSWHealth.org</email>
    </contact>
    <investigator>
      <last_name>Dion Graybeal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas (UT) Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Cameron, Study Coordinator</last_name>
      <phone>(214) 648-3748</phone>
      <email>Jan.CameronWatts@UTSouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Johnson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-2703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Wiese, Study Coordinator</last_name>
      <phone>(713) 441-7161</phone>
      <email>jrwiese@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>John J. Volpi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tricia Brannan, Study Coordinator</last_name>
      <phone>(703) 269-4759</phone>
      <email>tricia.brannan@inova.org</email>
    </contact>
    <investigator>
      <last_name>John Cochran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centra Medical Group Stroobants Cardiovascular Center</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Baumann, Study Coordinator</last_name>
      <phone>(434) 200-2727</phone>
      <email>Cindy.Baumann@Centrahealth.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Sackett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Saint Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate McPolin, Study Coordinator</last_name>
      <phone>(414) 385-7125</phone>
      <email>kate.mcpolin@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Rehan Sajjad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2016</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>This data is for internal, Medtronic use only. Data from the study will be analyzed and submitted in the form of abstracts and possible publication in a journal.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

